Letrozole in Preventing Breast Cancer in Postmenopausal Women
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. Letrozole may be effective in preventing the development
or recurrence of breast cancer in postmenopausal women who are at increased risk of
developing breast cancer because of elevated estradiol levels.
PURPOSE: This randomized phase II trial is studying how well letrozole works in preventing
breast cancer in postmenopausal women with elevated estradiol levels.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Jonsson Comprehensive Cancer Center National Cancer Institute (NCI)